Search details
1.
Five-year analysis of the prevention of colorectal sporadic adenomatous polyps trial.
Am J Gastroenterol
; 106(6): 1135-46, 2011 Jun.
Article
in English
| MEDLINE | ID: mdl-21503000
2.
Cytochrome P450 2C9 variants influence response to celecoxib for prevention of colorectal adenoma.
Gastroenterology
; 136(7): 2127-2136.e1, 2009 Jun.
Article
in English
| MEDLINE | ID: mdl-19233181
3.
Celecoxib for the prevention of colorectal adenomatous polyps.
N Engl J Med
; 355(9): 885-95, 2006 Aug 31.
Article
in English
| MEDLINE | ID: mdl-16943401
4.
Celecoxib for the prevention of sporadic colorectal adenomas.
N Engl J Med
; 355(9): 873-84, 2006 Aug 31.
Article
in English
| MEDLINE | ID: mdl-16943400
5.
Clinical characteristics and outcomes in familial adenomatous polyposis patients with a long-term treatment of celecoxib: a matched cohort study.
Fam Cancer
; 10(2): 303-8, 2011 Jun.
Article
in English
| MEDLINE | ID: mdl-21359561
6.
Statin use and colorectal adenoma risk: results from the adenoma prevention with celecoxib trial.
Cancer Prev Res (Phila)
; 3(5): 588-96, 2010 May.
Article
in English
| MEDLINE | ID: mdl-20403998
7.
Five-year efficacy and safety analysis of the Adenoma Prevention with Celecoxib Trial.
Cancer Prev Res (Phila)
; 2(4): 310-21, 2009 Apr.
Article
in English
| MEDLINE | ID: mdl-19336730
8.
Aberrant crypt foci in the adenoma prevention with celecoxib trial.
Cancer Prev Res (Phila)
; 1(1): 21-31, 2008 Jun.
Article
in English
| MEDLINE | ID: mdl-19138933
Results
1 -
8
de 8
1
Next >
>>